Study of a High-Risk Group of Stage II Colon Cancer

被引:0
|
作者
Hirosawa, Tomoichiro [1 ]
Itabashi, Michio [1 ]
Bamba, Yoshiko [1 ]
Ogawa, Shinpei [1 ]
Sirotani, Noriyasu [1 ]
Kameoka, Shingo [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Surg 2, Sch Med, Sinjuku Ku, Tokyo 1628666, Japan
关键词
Colon cancer; Stage II; Adjuvant chemotherapy; RECTAL-CANCER; EFFICACY; FLUOROURACIL; TRIAL;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study was conducted for the purpose of identifying a high-risk group for recurrence of stage II colon cancer and determine those cases for which postoperative adjuvant chemotherapy for stage II colon cancer is indicated. The subjects of this study consisted of 179 stage II cases and 114 stage IIIa cases among 462 surgical colon cancer cases examined at this department from January 1, 1991 to December 31, 1996 classified as A for the degree of cure, with the exception of m cancer. A nonrecurrence group and a recurrence group of stage II and stage IIIa colon cancer cases were compared on the basis of parameters. Gender, age, and lymph ducts were extracted from multivariate analysis, while age and lymph ducts were extracted from a survival analysis using the Cox proportional hazard model. A high-risk group for recurrence of stage II colon cancer was determined to consist of young men of ly 2.3. Since the nonrecurrence survival rates and survival prognoses of ly 2.3 cases in particular were equivalent to those of stage IIIa, this is considered to be a risk factor for recurrence of stage II colon cancer, and postoperative chemotherapy is believed to be indicated.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 50 条
  • [31] Clinical Implications of Mismatch Repair Status in Patients With High-risk Stage II Colon Cancer
    Baek, Dong Won
    Kang, Byung Woog
    Lee, Soo Jung
    Kim, Hye Jin
    Park, Su Yeon
    Park, Jun Seok
    Choi, Gyu Seog
    Baek, Jin Ho
    Kim, Jong Gwang
    IN VIVO, 2019, 33 (02): : 649 - 657
  • [32] High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
    Mohamed, Amr
    Jiang, Renjian
    Philip, Philip A.
    Diab, Maria
    Behera, Madhusmita
    Wu, Christina
    Alese, Olatunji
    Shaib, Walid L.
    Gaines, Tyra M.
    Balch, Glen G.
    El-Rayes, Bassel F.
    Akce, Mehmet
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer
    Kim, Y. T.
    Kim, H. S.
    Shin, S. J.
    Beom, S-H.
    Kim, N. K.
    Lee, K. Y.
    Min, B. S.
    Hur, H.
    Cho, M. S.
    Han, Y. D.
    Yang, S. Y.
    Koom, W. S.
    Chang, J. S.
    Kim, T. I.
    Cheon, J. H.
    Park, S. J.
    Park, J. J.
    Seo, N. E.
    Lim, J. S.
    Ahn, J. B.
    ANNALS OF ONCOLOGY, 2020, 31 : S418 - S419
  • [34] High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
    Park, Ji Soo
    Chon, Hong Jae
    Jeung, Hei-Cheul
    Shin, Sang Joon
    Rha, Sun Young
    Ahn, Joong Bae
    Lee, Kang Young
    Kim, Nam Kyu
    Chung, Hyun Cheol
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (09) : 2051 - 2059
  • [35] High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
    Ji Soo Park
    Hong Jae Chon
    Hei-Cheul Jeung
    Sang Joon Shin
    Sun Young Rha
    Joong Bae Ahn
    Kang Young Lee
    Nam Kyu Kim
    Hyun Cheol Chung
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 2051 - 2059
  • [36] Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer
    van den Bosch, Tom
    Miedema, Daniel M.
    Vermeulen, Louis
    JOURNAL OF PATHOLOGY, 2022, 257 (05): : 575 - 578
  • [37] Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer
    Lujing Yang
    Pengju Chen
    Li Zhang
    Lin Wang
    Tingting Sun
    Lixin Zhou
    Zhongwu Li
    Aiwen Wu
    British Journal of Cancer, 2020, 123 : 973 - 981
  • [38] Microsatellite Status Predicts Effectiveness of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
    Krishnamurty, Devi Mukkai
    Park, Yu-Soon A.
    Tashjian, Nara
    Aurit, Sarah J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S65 - S66
  • [39] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [40] A MICROSIMULATION MODEL FOR HIGH-RISK STAGE II AND STAGE III COLON CANCER SURVIVORS FOLLOWING THE CURRENT GUIDELINES
    Samur, S.
    Gursel, E.
    Gu, N. Y.
    Palomares, M.
    Sahinkoc, M.
    Hoban, O.
    Cuyun, Carter G.
    Ayer, T.
    Chhatwal, J.
    Parikh, A.
    Neugut, A., I
    VALUE IN HEALTH, 2024, 27 (06) : S14 - S14